Schwartz B F, Auman R, Peretsman S J, Moul J W, Deshon G E, Hernandez J, Rozanski R A, Thrasher J B
Department of Urology, Madigan Army Medical Center, Tacoma, Washington 98431-5000, USA.
J Surg Oncol. 1996 Feb;61(2):131-3. doi: 10.1002/(SICI)1096-9098(199602)61:2<131::AID-JSO7>3.0.CO;2-D.
Approximately 10-15% of patients with stage 1 pure seminoma of the testis have an elevated preorchiectomy serum beta human chorionic gonadotropin level [1-4]. The prognostic significance of this elevation is unknown. We performed a multi-institutional retrospective review of 332 men with stage I pure seminoma of the testis and evaluated the prognostic significance of this elevation and the prognostic value of local invasion of the primary tumor. Twenty-five of 191 evaluable patients (13%) had elevated preorchiectomy beta human chorionic gonadotropin. All normalized postoperatively and are alive without evidence of disease with a median follow-up of 50 months (range 1-124 mo). Of 191 patients, 190 (99.5%) are alive and free of disease. One patient underwent salvage chemotherapy for a chest recurrence, and he is alive and free of disease at 72 months. We conclude that elevated preorchiectomy serum beta human chorionic gonadotropin level and local invasion of the primary tumor do not portend a poor prognosis in patients with clinical stage I pure seminoma of the testis.
睾丸I期纯精原细胞瘤患者中,约10%-15%的患者在睾丸切除术前血清β-人绒毛膜促性腺激素水平升高[1-4]。这种升高的预后意义尚不清楚。我们对332例睾丸I期纯精原细胞瘤男性患者进行了多机构回顾性研究,评估了这种升高的预后意义以及原发肿瘤局部浸润的预后价值。191例可评估患者中有25例(13%)在睾丸切除术前β-人绒毛膜促性腺激素升高。术后所有患者的该指标均恢复正常,并且均存活,无疾病证据,中位随访时间为50个月(范围1-124个月)。191例患者中,190例(99.5%)存活且无疾病。1例患者因胸部复发接受了挽救性化疗,在72个月时存活且无疾病。我们得出结论,对于临床I期睾丸纯精原细胞瘤患者,睾丸切除术前血清β-人绒毛膜促性腺激素水平升高和原发肿瘤局部浸润并不预示预后不良。